124 related articles for article (PubMed ID: 14984475)
1. Germline-sequence variants S836S and L769L in the RE arranged during Transfection (RET) proto-oncogene are not associated with predisposition to sporadic medullary carcinoma in the French population.
Berard I; Kraimps JL; Savagner F; Murat A; Renaudin K; Nicolli-Sire P; Bertrand G; Moisan JP; Bezieau S
Clin Genet; 2004 Feb; 65(2):150-2. PubMed ID: 14984475
[No Abstract] [Full Text] [Related]
2. Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.
Ruiz A; Antiñolo G; Fernández RM; Eng C; Marcos I; Borrego S
Clin Endocrinol (Oxf); 2001 Sep; 55(3):399-402. PubMed ID: 11589684
[TBL] [Abstract][Full Text] [Related]
3. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.
Wiench M; Wygoda Z; Gubala E; Wloch J; Lisowska K; Krassowski J; Scieglinska D; Fiszer-Kierzkowska A; Lange D; Kula D; Zeman M; Roskosz J; Kukulska A; Krawczyk Z; Jarzab B
J Clin Oncol; 2001 Mar; 19(5):1374-80. PubMed ID: 11230481
[TBL] [Abstract][Full Text] [Related]
4. Does a somatic deletion in RET clarify the sporadic nature of medullary thyroid carcinoma?
Gimm O; Marsh DJ
J Endocrinol Invest; 2003 Apr; 26(4):381-3. PubMed ID: 12841548
[No Abstract] [Full Text] [Related]
5. Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.
Gimm O; Neuberg DS; Marsh DJ; Dahia PL; Hoang-Vu C; Raue F; Hinze R; Dralle H; Eng C
Oncogene; 1999 Feb; 18(6):1369-73. PubMed ID: 10022819
[TBL] [Abstract][Full Text] [Related]
6. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
Elisei R; Cosci B; Romei C; Bottici V; Sculli M; Lari R; Barale R; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.
Marsh DJ; Learoyd DL; Andrew SD; Krishnan L; Pojer R; Richardson AL; Delbridge L; Eng C; Robinson BG
Clin Endocrinol (Oxf); 1996 Mar; 44(3):249-57. PubMed ID: 8729519
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.
Machens A; Frank-Raue K; Lorenz K; Rondot S; Raue F; Dralle H
Clin Endocrinol (Oxf); 2012 May; 76(5):691-7. PubMed ID: 22111543
[TBL] [Abstract][Full Text] [Related]
10. A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule.
Maschek W; Pichler R; Rieger R; Weinhäusel A; Berg J
Clin Endocrinol (Oxf); 2002 Jun; 56(6):823. PubMed ID: 12072055
[No Abstract] [Full Text] [Related]
11. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Ponder MA; Ponder BA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):123-7. PubMed ID: 7641404
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
[No Abstract] [Full Text] [Related]
13. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
[No Abstract] [Full Text] [Related]
14. Evaluation of germline sequence variants of GFRA1, GFRA2, and GFRA3 genes in a cohort of Spanish patients with sporadic medullary thyroid cancer.
Borrego S; Fernández RM; Dziema H; Japón MA; Marcos I; Eng C; Antiñolo G
Thyroid; 2002 Nov; 12(11):1017-22. PubMed ID: 12490080
[TBL] [Abstract][Full Text] [Related]
15. [G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients].
Wohllk G N; Soto C E; Bravo A M; Becker C P
Rev Med Chil; 2005 Apr; 133(4):397-402. PubMed ID: 15953945
[TBL] [Abstract][Full Text] [Related]
16. Editorial review of "Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 RET germline mutations".
Wilhelm S; Prinz RA
Surgery; 2004 Apr; 135(4):447-8. PubMed ID: 15041969
[No Abstract] [Full Text] [Related]
17. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
[TBL] [Abstract][Full Text] [Related]
18. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
[TBL] [Abstract][Full Text] [Related]
19. Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.
Marsh DJ; Andrew SD; Learoyd DL; Pojer R; Eng C; Robinson BG
Hum Mutat; 1998; Suppl 1():S3-4. PubMed ID: 9452023
[No Abstract] [Full Text] [Related]
20. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA
Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
